Cellular Models of Alpha-Synuclein Aggregation: What Have We Learned and Implications for Future Study

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Alpha-synuclein aggregation is central to synucleinopathies like Parkinson's disease.
• Despite extensive research, the precise role of alpha-synuclein in disease remains incompletely understood.
• In vitro models offer controlled environments for studying protein function but often lack in vivo relevance.

Purpose of the Study:

• To review current literature on alpha-synuclein in various cell culture models.
• To evaluate the utility of different in vitro systems for studying synucleinopathy pathogenesis.
• To highlight advancements in modeling neurodegenerative diseases using stem cell-derived systems.

Main Methods:

• Review of recent scientific literature on alpha-synuclein and cell culture models.
• Analysis of different in vitro systems: immortalized cell lines, primary neurons, hiPSCs, BBB models, and brain organoids.
• Comparative assessment of model relevance for studying protein aggregation.

Main Results:

• Different cell culture models offer varying degrees of relevance for studying alpha-synuclein aggregation.
• Human induced pluripotent stem cells (hiPSCs) and brain organoids show promise in recapitulating aspects of neurodegenerative disease pathology.
• Limitations of traditional cell lines are being overcome by advanced stem cell-based models.

Conclusions:

• Advanced cell culture models, particularly those derived from hiPSCs and organoids, are crucial for understanding alpha-synuclein aggregation in Parkinson's disease.
• These models provide a more physiologically relevant platform than traditional cell lines for studying synucleinopathies.
• Continued development and application of these models will advance our understanding of disease mechanisms and therapeutic strategies.